COLLECTIONS
WORKFLOWS
Recent Finacing
Recent Raise
Palvella is a rare disease biopharmaceutical developing pathogenetically targeted therapies using its QTORIN rapamycin gel platform for rare genetic skin disorders, partnering with patient registries.
